A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors.

NCT01286974 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated early, Sponsor Decision

Conditions

Advanced Solid Tumors

Interventions

DRUG: [14C]linifanib
DRUG: ABT-869, linifanib

Sponsor

Abbott